NCT04294069View on ClinicalTrials.gov

Azithromycin Dose and PPROM Treatment: a Pilot Randomized Controlled Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 14, 2020

Primary Completion Date

December 27, 2020

Study Completion Date

April 1, 2021

Conditions
Preterm Premature Rupture of Membrane
Interventions
DRUG

Azithromycin 500 mg

500mg azithromycin PO for seven days starting on admission

DRUG

Azithromycin Oral Product

1000mg azithromycin PO once at admission

Trial Locations (1)

19107

Thomas Jefferson University Hospital, Philadelphia

All Listed Sponsors
collaborator

Christiana Care Health Services

OTHER

lead

Thomas Jefferson University

OTHER

NCT04294069 - Azithromycin Dose and PPROM Treatment: a Pilot Randomized Controlled Trial | Biotech Hunter | Biotech Hunter